Alnylam Pharmaceuticals <ALNY.O>: Barclays cuts target price to $450 from $527
ALNY•Related News
Avista Q2 adjusted EPS beats estimates on lower fuel costs
AVA•
Medicus UK unit Antev names Faisal Mehmud CEO effective Aug. 30
MDCX•
InMode holds annual shareholder meeting
INMD•
Marriott International's Q2 adj profit beats on fee growth
MAR•
Olin Corp <OLN.N>: Truist Securities cuts target price to $20 from $24
OLN•